A flexible agent-based modelling framework of multi-serotype pneumococcal carriage to evaluate vaccine strategies in large populations

Streptococcus pneumoniaeis a multi-serotype pathogen causing a substantial global burden of pneumonia and invasive bacterial disease. Pneumococcal conjugate vaccines have been implemented worldwide, protecting against colonisation and disease with selected high-burden serotypes, but in many settings, short-term effectiveness has been eroded by serotype replacement. Vaccines with broader serotype coverage have been developed, at the cost of immunogenicity against single serotypes. To determine the longer-term impact of these new formulations, we propose a novel modelling framework that evaluates the relationship between serotype-specific vaccine immunogenicity and effectiveness, comprising immunity, carriage and clinical models. Dynamics of individual serotypes are modelled over time, advancing existing paradigms that group all serotypes according to vaccine type. This framework is sufficiently flexible to consider diverse populations and vaccine implementation strategies. A retrospective analysis of sequential introduction of 7- and 13-valent pneumococcal conjugate vaccines in Australia validates and demonstrates the model.